These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Renal failure secondary to leukemic infiltration of kidneys in CLL--a case report and review of literature. Uprety D; Peterson A; Shah BK Ann Hematol; 2013 Jan; 92(2):271-3. PubMed ID: 22875063 [No Abstract] [Full Text] [Related]
25. Fludarabine: a review of the clear benefits and potential harms. Lukenbill J; Kalaycio M Leuk Res; 2013 Sep; 37(9):986-94. PubMed ID: 23787174 [TBL] [Abstract][Full Text] [Related]
27. New meets old: a case study and review of novel therapeutics for the treatment of CLL in older patients. Gupta NK; Andreadis C J Natl Compr Canc Netw; 2014 Oct; 12(10):1371-5. PubMed ID: 25313177 [TBL] [Abstract][Full Text] [Related]
28. Collision tumor between a spinal schwannoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: case report and review of the literature. Berti PP; Pirillo V; Rizzo P; Ria A; Mannelli F; Broger M Br J Neurosurg; 2023 Oct; 37(5):1266-1268. PubMed ID: 33249871 [TBL] [Abstract][Full Text] [Related]
29. Fulminant hepatitis due to human adenovirus. Ronan BA; Agrwal N; Carey EJ; De Petris G; Kusne S; Seville MT; Blair JE; Vikram HR Infection; 2014 Feb; 42(1):105-11. PubMed ID: 23979854 [TBL] [Abstract][Full Text] [Related]
30. Individualized fludarabine-based regimen in elderly patients with chronic lymphocytic leukemia/small lymphocytic lymphoma. Guo B; Zhu HL; Fan H; Li SX; Lu XC; Lin J; Ran HH; Zhai B; Yang Y Adv Ther; 2012 Feb; 29(2):178-86. PubMed ID: 22249944 [TBL] [Abstract][Full Text] [Related]
31. Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia. Robak T; Lech-Maranda E; Robak P Expert Rev Anticancer Ther; 2010 Oct; 10(10):1529-43. PubMed ID: 20942624 [TBL] [Abstract][Full Text] [Related]
32. Progress in the treatment of chronic lymphocytic leukemia: results of the German CLL8 trial. Molica S Expert Rev Anticancer Ther; 2011 Sep; 11(9):1333-40. PubMed ID: 21929307 [TBL] [Abstract][Full Text] [Related]
33. Fludarabine and cyclophosphamide using an attenuated dose schedule is a highly effective regimen for patients with indolent lymphoid malignancies. Tam CS; Wolf MM; Januszewicz EH; Prince HM; Westerman D; Seymour JF Cancer; 2004 May; 100(10):2181-9. PubMed ID: 15139062 [TBL] [Abstract][Full Text] [Related]
34. Rituximab, fludarabine, and cyclophosphamide versus fludarabine and cyclophosphamide for treatment of chronic lymphocytic leukemia: A systematic review with meta-analysis. Nunes AA; da Silva AS; Souza KM; Koury Cde N; de Mello LM Crit Rev Oncol Hematol; 2015 Jun; 94(3):261-9. PubMed ID: 25797826 [TBL] [Abstract][Full Text] [Related]